Published Papers & Misc - MIYAZAKI Yasunari

Division display  1 - 20 of about 248 ／  All the affair displays >>

  1. Masaki K, Suzukawa M, Sasano H, Harada N, Miyazaki Y, Katsura H, Tagaya E, Terada J, Hojo M, Sugimoto N, Nagase H, Kono Y, Hiranuma H, Gon Y, Takemura R, Irie M, Nakamura R, Kabata H, Miyata J, Fukunaga K. Corrigendum to "Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trial" [Allergol Int 74 (2025) 274-82]. Allergology international : official journal of the Japanese Society of Allergology. 2025.07; 74 (3): 494-496. ( PubMed, DOI )

  2. Cho H, Shiraishi K, Sunami K, Momozawa Y, Yoshida T, Matsumoto S, Matsuda K, Saito M, Goto A, Honda T, Mochizuki A, Torasawa M, Daigo Y, Shimizu K, Kunitoh H, Yoshida Y, Hirata M, Shimada Y, Ueki M, Ono H, Gotoh M, Igawa YS, Tateishi A, Yamaguchi Y, Higashiyama RI, Machida E, Iwasaki M, Kawai Y, Yasuda H, Hamamoto J, Imoto I, Matsushita H, Takata S, Aoi T, Kaneko S, Kuchiba A, Shimomura A, Fukami M, Hattori K, Ozaki K, Asano Y, NCBN Controls WGS Consortium, Project BJ, Takano A, Kobayashi M, Miyagi Y, Tanaka K, Suzuki H, Yamaura T, Yoshida T, Goto Y, Horinouchi H, Miyazaki Y, Ito H, Nagashima T, Ohtaki Y, Imai K, Minamiya Y, Okubo K, Inazawa J, Shiraishi Y, Tokunaga K, Kamatani Y, Yatabe Y, Goto K, Tsuboi M, Watanabe SI, Ohe Y, Murakami Y, Matsuo K, Hamamoto R, Kohno T. Genomic profiles of pathogenic and moderate-penetrance germline variants associated with risk of early-onset lung adenocarcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2025.06; ( PubMed, DOI )

  3. Okuda Ryo, Ogura Takashi, Hisata Shu, Baba Tomohisa, Kondoh Yasuhiro, Suda Takafumi, Johkoh Takeshi, Iwasawa Tae, Tomioka Hiromi, Bando Masashi, Azuma Arata, Inoue Yoshikazu, Ishikawa Nobuhisa, Arai Naoki, Takihara Takahisa, Hamaguchi Megumi, Arai Toru, Nakamura Yutaro, Miyamoto Atsushi, Tomii Keisuke, Miyazaki Yasunari, Chiba Hirofumi, Ishii Haruyuki, Hamada Naoki, Terasaki Yasuhiro, Fukuoka Junya, Sakai Fumikazu, Egashira Ryoko, Fujimoto Kiminori, Sumikawa Hiromitsu, Suzuki Takuji, Sakamoto Susumu, Nishioka Yasuhiko, Hattori Noboru, Hashimoto Naozumi, Morita Satoshi, Ichihara Nao, Miyata Hiroaki, Hagiwara Koichi, Kobayashi Kunihiko, Nukiwa Toshihiro. Prognostic prediction for newly diagnosed patients with idiopathic interstitial pneumonia: JIPS Registry (NEJ030)(タイトル和訳中) Respiratory Investigation. 2025.05; 63 (3): 365-372. ( ichushi )

  4. Masaki Katsunori, Suzukawa Maho, Sasano Hitoshi, Harada Norihiro, Miyazaki Yasunari, Katsura Hideki, Tagaya Etsuko, Terada Junko, Hojo Masayuki, Sugimoto Naoya, Nagase Hiroyuki, Kono Yuta, Hiranuma Hisato, Gon Yasuhiro, Takemura Ryo, Irie Misato, Nakamura Reina, Kabata Hiroki, Miyata Jun, Fukunaga Koichi. Effectiveness of benralizumab in the Tokyo Asthma Study(TOAST): A real-world prospective interventional trial(タイトル和訳中) Allergology International. 2025.04; 74 (2): 274-282. ( ichushi )

  5. Komatsuzaki Keiko, Otani Yoshio, Kageshima Hiroki, Sekino Yuki, Suzuki Yasuhiro, Ugajin Tsukasa, Tamaoka Meiyo, Yorozu Pariko, Hanazawa Ryoichi, Hirakawa Akihiro, Murakami Daisuke, Miyazaki Yasunari. Safety of local nasal immunotherapy using hypoallergenic birch pollen ointment in patients with pollen-food allergy syndrome: A preliminary study of five cases(タイトル和訳中) Allergology International. 2025.04; 74 (2): 336-339. ( ichushi )

  6. Okuda R, Ochi Y, Saiki R, Yamanaka T, Terao C, Yoshizato T, Nakagawa MM, Zhao L, Ohyashiki K, Hiramoto N, Sanada M, Handa H, Kasahara S, Miyazaki Y, Sezaki N, Shih LY, Kern W, Kanemura N, Kitano T, Imashuku S, Watanabe M, Creignou M, Chonabayashi K, Usuki K, Ishikawa T, Gotoh A, Atsuta Y, Shiraishi Y, Mitani K, Chiba S, Takaori-Kondo A, Miyano S, Kamatani Y, Haferlach T, Hellström-Lindberg E, Matsuda K, Yoshida Y, Makishima H, Nannya Y, Ogawa S. Genetic analysis of myeloid neoplasms with der(1;7)(q10;p10). Leukemia. 2025.03; 39 (3): 760-764. ( PubMed, DOI )

  7. Furusawa H, Shimada S, Sawada A, Tanaka K, Yamamoto K, Miyazaki Y. Composite Lymphoma after Treatment with Infliximab for Sarcoidosis and Ankylosing Spondylitis. Internal medicine (Tokyo, Japan). 2025.01; 64 (1): 129-132. ( PubMed, DOI )

  8. Arai Toru, Inoue Yoshikazu, Akasaka Keiichi, Masunaga Aiko, Fujita Masaki, Yamaguchi Etsuo, Saigusa Mika, Murakami Koji, Kurahara Yu, Tsuyuguchi Kazunari, Suzuki Takuji, Miyazaki Yasunari, Bando Masashi, Suda Takafumi. Severity and prognosis of COVID-19 complicated by autoimmune pulmonary alveolar proteinosis(タイトル和訳中) Respiratory Investigation. 2025.01; 63 (1): 20-26. ( ichushi )

  9. Nakayama Sayuka, Yoshizawa Ayuha, Tsurutani Junji, Yoshimura Kenichi, Aoki Gaku, Iwamoto Takayuki, Nagase Hiroyuki, Sugimoto Naoya, Kobayashi Konomi, Izumi Shinyu, Kato Terufumi, Miyazaki Yasunari, Kurihara Yasuyuki, Taira Naruto, Aihara Tomohiko, Kikawa Yuichiro, Mukai Hirofumi. Real-world incidence of and risk factors for abemaciclib-induced interstitial lung disease in Japan: a nested case-control study of abemaciclib-induced interstitial lung disease(NOSIDE)(タイトル和訳中) Breast Cancer. 2025.01; 32 (1): 177-185. ( ichushi )

  10. Okamoto Tsukasa, Hanafusa Mariko, Abe Taketomo, Shimamura Takashi, Ito Masaru, Wakai Yoko, Jinta Torahiko, Higa Katsuyuki, Kondoh Yasuhiro, Okouchi Yasumi, Okuda Ryo, Bando Masashi, Suda Takafumi, Tomioka Hiromi, Fujiwara Takeo, Takase Masato, Yoshihara Shigemi, Odajima Hiroshi, Miyazaki Yasunari. Estimated prevalence and incidence of hypersensitivity pneumonitis in Japan(タイトル和訳中) Allergology International. 2025.01; 74 (1): 66-71. ( ichushi )

  11. Furusawa Haruhiko, Shimada Sho, Sawada Atsushi, Tanaka Keisuke, Yamamoto Kouhei, Miyazaki Yasunari. Composite Lymphoma after Treatment with Infliximab for Sarcoidosis and Ankylosing Spondylitis(タイトル和訳中) Internal Medicine. 2025.01; 64 (1): 129-132. ( ichushi )

  12. Shimamura Takashi, Furusawa Haruhiko, Ejima Masaru, Ozawa Akane, Adachi Takuya, Tateishi Ukihide, Miyazaki Yasunari. Clinical characteristics and prognostic factors for MPO-ANCA positive interstitial lung disease: A comparative study of ANCA associated vasculitis(AAV)-ILD and pulmonary limited vasculitis(タイトル和訳中) Respiratory Investigation. 2025.01; 63 (1): 1-6. ( ichushi )

  13. Ito M, Honda T, Onishi I, Endo S, Mochizuki A, Nishiyama N, Sakakibara R, Takahashi S, Kumagai T, Hata K, Yoshii S, Nakamura K, Yamashita T, Tsukada Y, Chiaki T, Miyashita Y, Natsume I, Saitou K, Miyazaki Y. A strong association between TTF-1 expression and interstitial lung disease in predicting the efficacy of PD-1 inhibitor for nonsquamous NSCLC patients. ERJ open research. 2025.01; 11 (1): ( PubMed, DOI )

  14. Nakayama S, Yoshizawa A, Tsurutani J, Yoshimura K, Aoki G, Iwamoto T, Nagase H, Sugimoto N, Kobayashi K, Izumi S, Kato T, Miyazaki Y, Kurihara Y, Taira N, Aihara T, Kikawa Y, Mukai H. Real-world incidence of and risk factors for abemaciclib-induced interstitial lung disease in Japan: a nested case-control study of abemaciclib-induced interstitial lung disease (NOSIDE). Breast cancer (Tokyo, Japan). 2024.11; 32 (1): 177-185. ( PubMed, DOI )

  15. Shimamura T, Furusawa H, Ejima M, Ozawa A, Adachi T, Tateishi U, Miyazaki Y. Clinical characteristics and prognostic factors for MPO-ANCA positive interstitial lung disease: A comparative study of ANCA associated vasculitis (AAV)-ILD and pulmonary limited vasculitis. Respiratory investigation. 2024.11; 63 (1): 1-6. ( PubMed, DOI )

  16. Iijima Yuki, Furusawa Haruhiko, Yamana Takashi, Shibata Sho, Shirai Tsuyoshi, Okamoto Tsukasa, Tateishi Tomoya, Adachi Takuya, Kirimura Susumu, Miyazaki Yasunari. Reevaluating diagnosis in interstitial lung disease with a second multidisciplinary discussion(タイトル和訳中) Respiratory Investigation. 2024.11; 62 (6): 1027-1033. ( ichushi )

  17. Kondoh Y, Furukawa T, Hozumi H, Suda T, Egashira R, Jokoh T, Fukuoka J, Kuwana M, Teramachi R, Fujisawa T, Hasegawa Y, Ogura T, Miyazaki Y, Oyama S, Teramukai S, Horiguchi G, Naito A, Inoue Y, Ichikado K, Bando M, Tomioka H, Nishioka Y, Chiba H, Ebina M, Nakanishi Y, Satoh K, Shiratori Y, Hashimoto N, Ishii M. The providing multidisciplinary ILD diagnoses (PROMISE) study - study design of the national registry of Japan facilitating interactive online multidisciplinary discussion diagnosis. BMC pulmonary medicine. 2024.10; 24 (1): 511. ( PubMed, DOI )

  18. Sumikawa H, Komiya K, Egashira R, Tominaga J, Ueno M, Fukuda T, Yamada D, Takei R, Kataoka K, Kimura T, Kondoh Y, Ejima M, Shimamura T, Tateishi T, Tomioka H, Miyazaki Y, Suda T, Johkoh T. Validation of a computed tomography diagnostic model for differentiating fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis. Respiratory investigation. 2024.09; 62 (5): 798-803. ( PubMed, DOI )

  19. Kubota Natsushi, Okamoto Tsukasa, Shimada Sho, Yamana Takashi, Iijima Yuki, Sakakibara Rie, Shibata Sho, Honda Takayuki, Mitsumura Takahiro, Shirai Tsuyoshi, Furusawa Haruhiko, Tateishi Tomoya, Adachi Takuya, Kirimura Susumu, Miyazaki Yasunari. Solitary Pure Ground-glass Opacity Suspected of Being the Initial Presentation of Nonfibrotic Hypersensitivity Pneumonitis Internal Medicine. 2024.09; 63 (18): 2543-2546. ( ichushi )

  20. Bando M, Chiba H, Miyazaki Y, Suda T. Current challenges in the diagnosis and management of idiopathic pulmonary fibrosis in Japan. Respiratory investigation. 2024.09; 62 (5): 785-793. ( PubMed, DOI )

< PREV - NEXT >

To the head of this page.▲